Femasys (FEMY) Accumulated Expenses (2020 - 2026)
Femasys' (FEMY) quarterly Accumulated Expenses came in at $1.0 million in Q1 2026, up 595.78% YoY from $147275.0 in Q1 2025, and up 17.66% on a QoQ basis from $870910.0 in Q4 2025.
Femasys (FEMY) Accumulated Expenses (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Accumulated Expenses data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Accumulated Expenses rose 595.78% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 595.78% YoY) and the FY2025 annual result came in at $870910.0, up 33.83% from the prior year.
- Accumulated Expenses rose to $1.0 million in Q1 2026, from $870910.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $1.1 million in Q3 2024 to a low of $85191.0 in Q4 2022.
- A 5-year average of $606854.5 and a median of $569442.0 in 2023 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Accumulated Expenses plunged 85.89% — and 2023, when it soared 1170.8%.
- Tracing FEMY's Accumulated Expenses over 5 years: stood at $85191.0 in 2022, then soared by 1170.8% to $1.1 million in 2023, then slumped by 39.89% to $650768.0 in 2024, then jumped by 33.83% to $870910.0 in 2025, then advanced by 17.66% to $1.0 million in 2026.
- The last three Accumulated Expenses figures came in at $1.0 million (Q1 2026), $870910.0 (Q4 2025), and $350338.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Femasys | 9.97 Mn | 8.53 Mn | 189,391.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | 870,910.00 |
| Sep 30, 2025 | 350,338.00 |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 147,275.00 |
| Dec 31, 2024 | 650,768.00 |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 250,025.00 |
| Mar 31, 2024 | 673,457.00 |
| Dec 31, 2023 | 1.08 Mn |
| Sep 30, 2023 | 569,442.00 |
| Jun 30, 2023 | 129,323.00 |
| Mar 31, 2023 | 535,417.00 |
| Dec 31, 2022 | 85,191.00 |
| Sep 30, 2022 | 649,615.00 |
| Jun 30, 2022 | 551,828.00 |
| Mar 31, 2022 | 565,228.00 |
| Dec 31, 2021 | 603,787.00 |
| Sep 30, 2021 | 597,856.00 |
| Jun 30, 2021 | 430,183.00 |